Lindsay A. Rosenwald

Rosenwald has served as a member of our Board of Directors since inception. From November 2014 to August 2015, he also was our Chief Executive Officer and President. Dr. Rosenwald additionally serves as Chairman, President and Chief Executive Officer of Fortress Biotech, as a director of Mustang Bio, and as Chairman of the Board of Directors of Avenue Therapeutics. Dr. Rosenwald co-founded Opus Point Partners Management, an asset management firm in the life sciences industry, in 2009 and serves as its Co-Portfolio Manager and Partner. Previously, from 1991 to 2008, he held the role of the Chairman of Paramount BioCapital. Over the last 23 years, Dr. Rosenwald has acted as a biotechnology entrepreneur and has been involved in the founding and recapitalization of numerous public and private biotechnology and life sciences companies. Dr. Rosenwald received his B.S. in finance from Pennsylvania State University and his M.D. from Temple University School of Medicine.